Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Receptos Inc (RCPT) Up On Bullish Takeover Report: Is It A Buy Now?

Page 1 of 2

Receptos Inc (NASDAQ:RCPT) is up by around 4% in the last few days, mainly due to a report released by Wedbush on Wednesday which suggested the company could be acquired for $348 per share, a significant potential windfall of nearly 100% for investors. Yet should that be enough to get people to buy the stock, or is the recent report a little too speculative, considering the recent insider sales made by company officials, which would seem to rule out any immediate sale of the company?


We look at the hedge fund sentiment and insider sentiment in order to gauge the interest and potential of stocks. In the case of Receptos Inc (NASDAQ:RCPT), the number of hedge fund positions in the stock went down by 4 at the end of the first quarter from 38 hedge fund positions in the stock at the end of Q4. This is an 11% drop in hedge fund ownership in the stock. Hedge fund sentiment is negative, but analysts are bullish about the stock. So is this stock a buy at the moment?

General opinion is that hedge funds under perform the S&P 500 based on net returns. But we are missing something very important here. Hedge funds generally pull in strong returns from their top small-cap stocks and invest a lot of their resources into analyzing these stocks, they simply don’t take large enough positions in them relative to their portfolios to generate strong overall returns because their large-cap picks underperform the market. We share the top 15 small-cap stocks favored by the best hedge fund managers every quarter and this strategy has managed to outperform the S&P 500 every year since it was launched in August 2012, returning over 142% and beating the market by more than 82 percentage points (read the details). So we know that collective hedge fund sentiment is extremely telling and valuable.

Lets take a look at the insider sentiment now to get more insight on the stock. There were no insider purchases made in the first quarter, but as mentioned, there was a significant amount of insider selling. Director of Receptos Inc (NASDAQ:RCPT), Edward S. Torres sold 220,000 shares on Tuesday in just one such move. Torres also sold around 53,000 shares in February. This clearly shows that insider sentiment for the stock is not positive, which seems to go against the sale thesis proposed by Wedbush.

Keeping this in mind, let’s take a glance at the hedge fund action on Receptos Inc (NASDAQ:RCPT).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!